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former). 50% of patients had positive family history for general cancer 
occurrence. The mean age of patients at the time of the ﬁrst carcinoma 
diagnosis was 59 years, 63 years at second carcinoma and 64 years at 
a third carcinoma diagnoses. The most common duplicity according 
together with lung cancer in men was another lung cancer type, while 
in women it was cervical cancer.
Vast majority of patients were smokers (current or former), which cor-
responds to smoking being an important risk factor in head and neck, 
larynx, lung, urine bladder, kidney, cervix and colon cancers. In addi-
tion, complex genetic factors, such as inherited disease susceptibility 
though multiple DNA variations seem responsible of frequent positive 
family history of general cancer occurrence. The role of chemotherapy 
and radiotherapy in the primary carcinoma treatment should be also 
considered as an independent risk factor for subsequent malignancies.
Conclusion The frequency of multiple carcinomas occurrence is 
steadily increasing over the past ten years. Paradoxically, gradual 
improvements in treatment efﬁciency directed at the primary tumor, 
gives opportunity for secondary carcinomas to develop. In addition to 
the possibility of disease relaps it is therefore very important to keep in 
mind an increased risk of a secondary malignity risk in oncologic pa-
tients. This study is further expected to be extended by other common 
risk analysis - including professional exposure, genetic and dietetics 
inﬂuence as well as other factors.
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Background: There were large increases in smoking in developing 
countries, especially among males, over the last part of the 20th centu-
ry. While prevalence of tobacco use has declined in some high income 
countries, it is increasing in some low and middle income countries, 
especially among young people and women. Smoking causes substan-
tially increased risk of mortality from lung cancer and a range of other 
medical causes. Among industrialized countries, where smoking has 
been common, smoking is estimated to cause over 90% of lung cancer 
in men and about 70% of lung cancer among women. Worldwide, it is 
estimated that tobacco causes about 8.8% of deaths (4.9 million) and 
4.1% of DALYs (59.1 million). The rapid evolution of the tobacco 
epidemic is illustrated by comparing these estimates for 2000 with 
those for 1990: there are at least a million more deaths attributable to 
tobacco, with the increase being most marked in developing countries. 
For industrialized countries, with just over one-ﬁfth of the world’s 
population, tobacco is the leading risk factor, accounting for about 12% 
of all disease and injury burden (about 2.5% of cancer burden). The 
aim of this study was to estimate smoking habits and associated factors 
among the medical students of Shaheed Beheshti University of Medical 
Sciences in Tehran. 
Methods: A cross-sectional survey conducted on 720 medical students 
(400 women and 320 men) by choosing randomly in Shaheed Be-
heshti University. Data collected by anonymous and Self-administered 
questionnaires. It included questions about demographic characteristics, 
family characteristics, social contacts, smoking pattern and use of other 
substances. The Completed questionnaires were thrown in a box by 
themselves. Logistic regression was used to analyze the inﬂuence of 
different factors on the probability of a medical student being a smoker.
Results: This study revealed the following results among medical 
students of Shaheed Beheshti University of Medical sciences: Over-
all, 14.2% of the medical students (24.7% of men; 5.8% of women) 
currently and regularly smoked; 15.7% of smokers were single, 80.4% 
were married and 3.9% were divorced. 7.1% of smokers reported start-
ing smoking at primary school (aged 7-11 years), 12.5% at guidance 
school (aged 12-14 years), 37% at high school (aged 15-18 years) and 
43.4% at the university (aged over 19 years). 
Male gender, being single, the worse relationship between medical 
students’ parents, alcohol and drug use in students, drug use in students’ 
friends and the place where students lived were found to be signiﬁcant 
variables predicting regular smoking by multivariate logistic regression 
analysis. Family status, relationship with father, alcohol and drug use 
in students’ families, alcohol use in students’ friends and prayer were 
found not to have inﬂuence on regular smoking. 
Conclusion: Smoking still constitutes a major problem among medi-
cal students. This may be due to the addictive effect of smoking and 
other reasons. More effective interventions that reduce smoking in the 
medical students should be implemented immediately so that medical 
students (next physicians) will be better able to fulﬁll their function as 
role models for the general population.
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Background: The presence of EGFR mutations in NSCLC has strong-
ly associated with never-smoking history. SHS exposure is associated 
with higher risk of lung cancer. We have conducted this study to evalu-
ate the association between SHS exposure and likelihood of mutations 
in EGFR gene in NSCLC patients who had never smoked.
Methods: SHS exposure information from a total of 93 never smok-
ers (<100 lifetime cigarettes) with newly diagnosed primary NSCLC 
was obtained using a standardized questionnaire. Patients were asked 
whether they were regularly exposed to SHS at home or work places, 
respectively. Nucleotide sequencing of the kinase domain of EGFR 
(exons 18 to 21) was performed using nested PCR ampliﬁcation of 
individual exons. 
Results: Patient characteristics (n=93) included median age 57 years; 
female (n= 81); adenocarcinoma ± bronchoalveolar carcinoma (n= 82); 
EGFR mutation (1 mutation in exon 18 G719, 31 in-frame deletions 
in exon 19, 10 mutations in codon 858 in exon 21). Fifty-two (55.9%) 
of the patients reported having been exposed to SHS, including 46 
(49.5%) exposed at home and 13 (14.0%) exposed at work. The inci-
dence of EGFR mutations was not associated with female gender and 
adenocarcinoma histology. Patients with SHS exposure showed a trend 
towards lower incidence of EGFR mutations (36.5% vs. 56.1%, P= 
0.060) and a signiﬁcantly lower incidence of deletion mutations in exon 
19 (57.9% vs. 87.0%, P= 0.033). When the incidence of EGFR muta-
tions was compared, no difference between SHS exposure at home and 
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work places was found. No signiﬁcant differences were found for other 
clinicopathological factors according to SHS exposure. 
Conclusions: Our results indicate weak evidence of relationship 
between likelihood of mutation in EGFR gene and SHS exposure. 
The deletion mutations in exon 19 were signiﬁcantly less common in 
patients with SHS exposure.
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Background: Lung carcinogenesis, is a multistage process involving 
alterations in multiple genes and diverse pathways. Inherited polymor-
phisms in a variety of genes, most notably the carcinogen metabolism, 
DNA repair and cell cycle control, may affect the susceptibility of an 
individual to develop lung cancer and prognosis, particularly in combi-
nation with environmental exposures. 
Methods: To comprehensively evaluate the impact of variation in the 
carcinogen metabolism, DNA repair and Cell cycle control pathway 
on lung cancer risk and prognosis, a hospital based case control study 
using 211 lung cancer patients and 211 healthy controls was carried out 
using polymerase chain reaction-restriction fragment length polymor-
phism assay. The distribution of each polymorphism among the cases 
and controls were determined and odds-ratios for the association of 
a particular polymorphism was analyzed using unconditional logistic 
regression model. Probability value at the <0.05 level of signiﬁcance 
was calculated. To assess the prognostic value of these SNPs, geno-
type- survival associations were also evaluated. The study subjects 
were followed up and overall survival was evaluated in Kaplan-Meier 
survival functions and Cox proportional hazards models. 
Results: The polymorphic deletions of the GSTM1 and GSTT1 genes 
was detected by PCR-based assays. PCR RFLP assays was used to 
genotype polymorphisms in GSTP1 (A1578G), CYP1A1 (T6235C), 
CYP2D6 (G1934A), XRCC1 (G28152A), XPD (A35931C ) and p53 
(Codon 72 C>G). Median age of patients was 59 years (Range, 20 to 84 
years) and in controls the median age was 57 years (Range 22-80 years) 
13.7% of patients were females compared to 12.8% in controls. Surviv-
al data were available for 170 (80%) patients. The risk prone genotypes 
were CYP1A1 TC (P=0.03*), CYP1A1 CC (P= .001*), GSTT1-/- ( 
P=0.001*), GSTP1 GG(P= 0.02*),CYP2D6 GA (P=0.04*),CYP2D6 
GG (P= 0.03*), XRCC1 399 AA (P=0.007*), XPD 751 AC (P=0.003*), 
p53 CC (P= 0.003*). Several of the genotype combinations involving 
came signiﬁcant in our study. Overall survival was determined from 
the time of LC diagnosis until death; patients alive or lost at follow-up 
were censored. Median survival time (MST) was 10 months and there 
were 66 deaths. Kaplan-Meier survival estimates for overall Survival 
revealed shorter overall survival for CYP1A1 (P=0.007*),CYP2D6 ( 
P=0.01*),GSTT1 null ( P=0.03*), XRCC1 399
(P=0.01*), p53 ( P=0.04*) respectively, by log-rank test. Multivari-
ate analysis using Cox Proportional Hazard model showed Signiﬁ-
cant Hazard Ratio for GSTT1-/- (HR=2.1, 95% CI: 1.158-4.116, 
P=0.01*),CYP1A1 CC (HR=2.3, 95% CI: 1.127-4.779, P=0.002*), 
XRCC1 399AA (HR=3.0, 95% CI: 1.393-6.670, P=0.005*), p53 codon 
72 CG (HR=2.2, 95% CI: 1.121-4.692), P=0.02*) and emerged as 
independent prognostic factors for overall survival. 
Conclusions: These ﬁndings suggest role of speciﬁc genetic variants in 
lung cancer susceptibility and that genetic polymorphisms may modu-
late overall lung cancer prognosis.
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Background: In the last 20 years lung cancer became the ﬁrst cause 
of death in women, exceeding also breast cancer. Many published retro-
spective studies suggest differences in the outcome between men and 
women as well as in terms of incidence and response to therapy. 
Patient and Methods: This is an Italian multicenter, prospective, 
consecutive case registration of patients (pts) with diagnosis of lung 
cancer. Starting from January 2006 we collected 100 cases of women 
(W) with newly diagnosis of lung cancer and we extrapolated from the 
database information collected in the same period of time about 100 
cases in men (M) adjusted for clinical stage and histotype. For women 
information about hormonal status was also collected. 
Results: With a minimal follow-up of six months the main patient 
characteristics are as follows: median age 60 years old (W =61, range 
40-85; M= 65, range 39-75), smokers 74% (W= 57%, M= 92%), PS 
0-1 91% (W= 75%, M= 98%), adenocarcinoma 44% (W= 48%, M= 
42%), squamous 14% (W= 16%, M= 13%), other NSCLC 29% (W= 
24%, M= 35%), SCLC 11% (W= 12%, M= 11%). Further information 
is summarized in the following table:
Histotype Stage Gender Surgery
Chemo-
therapy
Radio-
therapy
SCLC LD W 7% O 2% 7%
  M 7% O 2% 5%
 ED W 5% O O 5%
  M 5% O O 5%
NSCLC I-II W 19% 19% O 5%
  M 13% 13% O 1%
 IIIA W 9% 6% 2% 9%
  M 12% 8% 2% 12%
 IIIB W 12% 3% 3% 12%
  M 24% 3% 11% 23%
 IV W 48% O 10% * 48%
  M 39% 4% # 13% * 39%
#relapse after radical surgery; *palliative radiotherapy
